Commodore Capital’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,079,756
| Closed | -$3.85M | – | 30 |
|
|
2022
Q1 | $3.85M | Hold |
3,079,756
| – | – | 0.86% | 22 |
|
|
2021
Q4 | $3.57M | Hold |
3,079,756
| – | – | 0.83% | 22 |
|
|
2021
Q3 | $5.91M | Buy |
3,079,756
+150,309
| +5% | +$289K | 1.56% | 21 |
|
|
2021
Q2 | $6.86M | Buy |
2,929,447
+57,823
| +2% | +$135K | 2.39% | 17 |
|
|
2021
Q1 | $7.78M | Buy |
2,871,624
+1,105,723
| +63% | +$3M | 3.1% | 14 |
|
|
2020
Q4 | $4.27M | Buy |
+1,765,901
| New | +$4.27M | 2.32% | 21 |
|